Document:

Exhibit 10.1

 

 

February 1, 2018

 

 

William Febbo

154 Vassal Lane

Cambridge, MA

02138

 

Dear Will:

 

On behalf of OptimizeRx Corporation (the “Company” or
“OptimizeRx”), the following will update and amend your letter agreement dated February 12, 2016 (the “Offer
Letter”) concerning your employment as Chief Executive Officer of the Company, which commenced on February 22, 2016 (the
“Hire Date”). This role will continue to report directly to the Board of Directors. You will continue to serve as a
member of the Company’s board of directors. The Company is located in Rochester, Michigan, but the Company recognizes you
live in Cambridge, Massachusetts and will require extensive travel.

 

Compensation 

 

Effective January 1, 2018, your base salary will increase to $275,000.00
annually, and will increase to $300,000 effective January 1, 2019. You will be paid semi-monthly in accordance with our normal
payroll procedure. All forms of compensation referred to in this letter agreement are subject to reduction to reflect applicable
withholding and payroll taxes and other deductions required by law, except as otherwise agreed herein. Your annual compensation
will be reviewed by the compensation committee or the board of directors annually and will be adjusted at their discretion.

 

Bonus 

 

As Chief Executive Officer, you are eligible for a bonus as outlined
herein. Your annual bonus target will be 50% of your annual salary, payable in a lump sum at such time as may be determined by
our Board of Directors, but no later than the earlier of ten (10) business days after we finalize our audited financial statements
for the fiscal year; or one hundred and fifty (150) days following the end of such fiscal year. To be eligible to receive a payment,
you must be employed by OptimizeRx at the time any bonuses are paid as set forth in more detail in the terms of the plan. Whether
a bonus will be awarded, and in what amount, will be based on revenue goals and EBITDA as set forth in our bonus plan. Each year,
you will have 30 days to review the proposed goals and present any changes to the board for their approval.

 

Equity 

 

As Chief Executive Officer, you were granted a one-time stock option
to purchase one million five hundred thousand (1,500,000) shares of restricted common stock (the “Option Grant”) under
the OptimizeRx 2013 Inventive Plan (the “Plan”). The Option Grant originally vested in 20% increments annually on each
of the grant; first, second, third, fourth, and fifth anniversaries of the original grant date. The vesting schedule is hereby
modified to vest the increment originally vesting on the fifth anniversary to vest on the 2nd anniversary. The exercise
price per share of these stock options remains the thirty (30) day average of OptimizeRx’s closing price per share prior
to the Hire Date. Your Option Award will be subject to all the terms, conditions and restrictions of the Form of Option Grant Agreement
and the Plan. Attachment A to the Offer Letter, which is incorporated herein by reference, sets forth the terms and conditions
of your Form of Option Grant Agreement.

    	 

     

    

2 | Page 

 

 

In addition, as soon as is practicable after the full execution
of this letter, the Company will grant to you 240,000 performance-based RSUs. The RSUs will fully vest, in a number determined
based on performance compared to the goals and terms stated in Attachment A to this letter agreement, by the end of 2019.

 

Benefits 

 

You will be entitled to continue to participate in OptimizeRx’s
health and welfare benefit programs and four weeks of vacation and other benefit programs for which other employees of OptimizeRx
are generally eligible, subject to any eligibility requirements of such plans and programs.

 

Additionally, travel and accommodations shall be provided during
required time within the corporate offices per approved travel budget from board.

 

The Company will pay all premiums for a term life insurance policy
for you in the amount of $4,000,000 (Four Million Dollars). You will have the opportunity to designate one or more beneficiaries
of such policy.

 

Severance Benefits 

 

If (i) your employment is terminated by us without Cause (as defined
below), (ii) you resign following an event constituting Good Reason (as defined below), provided that you have given written notice
to the Company of such event within forty-five (45) days of its occurrence and the Company has failed to cure such event within
thirty (30) days following receipt of such notice, or (iii) you no longer render services to us as a result of your death
or Disability (as defined below), then you will receive a severance payment in the amount equal to twelve (12) months of your then
applicable base pay, less applicable withholding taxes and regular deductions, payable in a lump sum (“Severance Benefits”).
Health benefits will also be provided, at the Company’s sole expense during the applicable severance term.

 

Your receipt of the foregoing Severance Benefits is conditioned
on you having first executed, and not revoked, a general release of claims in favor of OptimizeRx (in a form reasonably prescribed
by us) and the return of all OptimizeRx property. The Severance Benefits will be paid in the form of a lump sum, in accordance
with our standard payroll procedures, within sixty (60) days following your “separation from service,” as defined
under Section 409A of the Internal Revenue Code of 1986, as amended (the “Code”) (subject to a six-month delay if you
are a “specified employee” as defined under the Treasury Regulations under Section 409A of the Code and such delay
is required to avoid the penalty taxes that otherwise may be imposed by Section 409A of the Code).

 

To the extent that any provision of this letter agreement is ambiguous
as to its exemption or compliance with Code Section 409A, the provision will be read in such a manner so that all payments hereunder
are exempt from Code Section 409A to the maximum permissible extent, and for any payments where such construction is not tenable,
that those payments comply with Code Section 409A to the maximum permissible extent. To the extent any payment under this letter
agreement may be classified as a “short-term deferral” within the meaning of Code Section 409A, such payment shall
be deemed a short-term deferral, even if it may also qualify for an exemption from Code Section 409A under another provision of
Code Section 409A. Payments pursuant to this Offer Letter (or referenced in this Offer Letter) are intended to constitute separate
payments for purposes of Section 1.409A-2(b)(2) of the regulations under Code Section 409A.

    	 

     

    

 

3 | Page 

 

 

“Cause” means your (i) gross negligence or willful
misconduct in the performance of your duties, in each case in a manner that causes material harm to the Company; (ii) commission
of any act of fraud or material dishonesty with respect to the Company; (iii) conviction of, or plea of guilty or “no
contest” to, a felony or a crime of moral turpitude or dishonesty; (iv) material breach of any proprietary information
and inventions agreement with the Company, including the Employee Confidentiality, Invention Assignment and Non-Compete Agreement,
or any other unauthorized use or disclosure of the OptimizeRx’s confidential information or trade secrets; or (v) repeated
failure to perform the duties reasonably assigned to you in a manner that causes material harm to the Company.

 

“Disability” means (i) a permanent and total disability
that entitles you to disability income payments under any long-term disability plan or policy provided by the Company under which
you are covered, as such plan or policy is then in effect; or (ii) if you are not covered under a long-term disability plan or
policy provided by the Company at such time for whatever reason, then the term “Disability” means that you are unable
to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment which can be
expected to result in death or which has lasted, or can be expected to last, for a continuous period of not less than 12 months,
and, in this case, the existence of any such Disability shall be certified by a physician reasonably acceptable to the Company.

 

“Good Reason” means (i) a material reduction or
change in your duties, responsibilities, authority, power or function; or (ii) a material reduction in your annual compensation,
including base salary and bonus (assuming all applicable target goals are met).

 

Change of Control Benefits 

 

In the event of your Qualifying Termination (as defined below),
within twelve (12) months following a Change in Control (as defined below) during which you were actively employed, you will
receive (i) twelve (12) months of your final base pay rate; and (ii) if the Company’s equity awards are assumed in the
Change in Control, accelerated vesting of the number of your then-unvested Company stock option shares it being acknowledge and
agreed that this section shall supersede any language to the contrary in any other document including the Form of Option Grant
Agreement (collectively, the “Change in Control Benefits”). The Change in Control Benefits would be provided in lieu
of any other severance-related benefits for which you may be eligible. Your receipt of the Change in Control Benefits is conditioned
on you having first executed, and not revoked, a general release of claims in favor of the Company (in a form reasonably prescribed
by the Company) and the return of all Company property.

 

“Qualifying Termination” means (i) a termination
of your employment by the Company or its successor without Cause (as defined above) or (ii) your resignation within three
(3) months following an event constituting Good Reason (as defined above), provided that you have given written notice to
the Company of such event within forty-five (45) days of its occurrence and the Company has failed to cure such event within
thirty (30) days following receipt of such notice.

 

“Change in Control” means: (i) the sale or other disposition
of all or substantially all of the assets of the Company; (ii) any sale or exchange of the capital stock of the Company by the
stockholders of the Company in one transaction or series of related transactions where more than fifty percent (50%) of the outstanding
voting power of the Company is acquired by a person or entity or group of related persons or entities; (iii) any reorganization,
consolidation or merger of the Company where the outstanding voting securities of the Company immediately before the transaction
represent or are converted into less than fifty percent (50%) of the outstanding voting power of the surviving entity (or its parent
corporation) immediately after the transaction; or (iv) the consummation of the acquisition of fifty-one percent (51%) or more
of the outstanding stock of the Company pursuant to a tender offer validly made under any federal or state law (other than a tender
offer by the Company). Notwithstanding the foregoing, a transaction will not be deemed a Change in Control unless the transaction
qualifies as a change in control event within the meaning of Section 409A of the Code.

    	 

     

    

4 | Page 

 

Section 280G

 

If any of the payments or benefits received or to be received by
you from the Company (including, without limitation, any payment or benefits received in connection with a Change in Control or
the termination of your employment, whether pursuant to the terms of this letter agreement or any other plan, arrangement, or agreement,
or otherwise) (all such payments collectively referred to herein as the “280G Payments”) constitute “parachute
payments” within the meaning of Section 280G of the Code and will be subject to the excise tax imposed under Section 4999
of the Code (the “Excise Tax”), the Company shall pay to you, no later than the time such Excise Tax
is required to be paid by you or withheld by the Company, an additional amount equal to the sum of the Excise Tax payable by you,
plus the amount necessary to put you in the same after-tax position (taking into account any and all applicable federal, state,
and local excise, income, or other taxes at the highest applicable rates on such 280G Payments and on any payments under this Section
5.9 or otherwise) as if no Excise Tax had been imposed.

 

Employment Eligibility Verification 

 

For purposes of federal immigration law, you will be required to
provide to us documentary evidence of your identity and eligibility for employment in the United States. Such documentation must
be provided to us within three (3) business days of your Hire Date, or our employment relationship with you may be terminated.

 

Employment at Will 

 

If you choose to accept this offer, your employment with us will
be voluntarily entered into and will be for no specified period. As a result, you will be free to resign at any time, for any reason,
as you deem appropriate. We will have a similar right and may terminate our employment relationship with you at any time, with
or without Cause or advance notice.

 

Exclusive Employment

 

While you render services to us, you agree that you will not engage
in any other employment, consulting or other business activity without our prior written consent.. While you render services to
us, you also will not assist any person or entity in competing with us, in preparing to compete with us or in hiring any of our
employees or consultants.

 

Confidentiality, Invention Assignment and Non-Compete

 

As a condition of employment, you will be required to execute the
Employee Confidentiality, Invention Assignment and Non-Compete Agreement between you and the Company. Please see Attachment C to
the Offer Letter, which is incorporated herein by reference, for the complete terms and conditions this agreement.

 

    	 

     

    

 

  5 | Page 

 

 

Choice of Law, Exclusive Venue

 

THIS AGREEMENT, AND ALL ISSUES AND QUESTIONS CONCERNING THE CONSTRUCTION,
VALIDITY, ENFORCEMENT AND INTERPRETATION OF THIS AGREEMENT, WILL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE INTERNAL
LAWS OF THE STATE OF MICHIGAN, WITHOUT GIVING EFFECT TO ANY CHOICE OF LAW OR CONFLICT OF LAW RULES OR PROVISIONS (WHETHER THE STATE
OF MICHIGAN OR ANY OTHER JURISDICTION) THAT WOULD CAUSE THE APPLICATION OF THE LAWS OF ANY JURISDICTION OTHER THAN THE STATE OF
MICHGAN. THE PARTIES AGREE THAT ALL DISPUTES, LEGAL ACTIONS, SUITS AND PROCEEDINGS ARISING OUT OF OR RELATING TO THIS AGREEMENT
MUST BE BROUGHT EXCLUSIVELY IN A FEDERAL OR STATE COURT LOCATED IN DETROIT, MICHIGAN (COLLECTIVELY THE "DESIGNATED COURTS").

 

EACH PARTY HEREBY CONSENTS AND SUBMITS TO THE EXCLUSIVE JURISDICTION
OF THE DESIGNATED COURTS. NO LEGAL ACTION, SUIT OR PROCEEDING WITH RESPECT TO THIS AGREEMENT MAY BE BROUGHT IN ANY OTHER FORUM.
EACH PARTY HEREBY IRREVOCABLY WAIVES ALL CLAIMS OF IMMUNITY FROM JURISDICTION AND ANY OBJECTION WHICH SUCH PARTY MAY NOW OR HEREAFTER
HAVE TO THE LAYING OF VENUE OF ANY SUIT, ACTION OR PROCEEDING IN ANY DESIGNATED COURT, INCLUDING ANY RIGHT TO OBJECT ON THE BASIS
THAT ANY DISPUTE, ACTION, SUIT OR PROCEEDING BROUGHT IN THE DESIGNATED COURTS HAS BEEN BROUGHT IN AN IMPROPER OR INCONVENIENT FORUM
OR VENUE.

 

Acceptance of Offer 

 

To indicate your acceptance of the terms of this offer, please sign
and date in the space provided below and return an executed copy to: OptimizeRx, 400 Water Street, Suite 200, Rochester, MI 48307,
Attention: Douglas Baker, CFO.

 

This letter agreement, and all of its attachments, constitute the
entire agreement between you and us regarding the terms and conditions of your employment with OptimizeRx and together supersede
any prior representations or agreements, whether written or oral. This letter, along with any attachments hereto, may not be modified
or amended except by a written agreement signed by an authorized person of OptimizeRx.

 

 

If you have any questions regarding this offer, please feel
free to contact me.

	Sincerely,	 	 
	 	 	 
	 	 	 
	 	 	 
	OptimizeRx Corporation	 	 
	 	 	 

 

 

    	 

     

    

 6 | Page 

 

 

I accept OptimizeRx’s updated offer of employment and agree
to the terms in this letter agreement and its attachments. I accept this offer voluntarily and not in reliance on any promises
other than those contained in this letter agreement and its attachments.

 

	 	 	 
	William Febbo	 	 
	 	 	 
	 	 	 
	DateExhibit

Exhibit 10.1

Form of Award Notice for Return on Capital Performance Shares under 
the National Fuel Gas Company 2010 Equity Compensation Plan

Name
Address

Dear _________:

I am pleased to inform you that on [date of grant] the Compensation Committee (“Committee”) of the Board of Directors of National Fuel Gas Company (the “Company”) granted to you (the “Grantee” or “you”)  ____ Performance Shares under the National Fuel Gas Company 2010 Equity Compensation Plan (the “Plan”), subject to a Performance Goal related to return on capital, as set forth in this Award Notice.  Performance Shares are an award, pursuant to Section 9 of the Plan, constituting units denominated in Common Stock, the number of which such units may be adjusted over a Performance Cycle based upon the extent to which Performance Goals have been satisfied.  
The Performance Shares covered by this letter agreement (“Award Notice”) may be referred to in this Award Notice as “Your ROC Performance Shares.”  The number of Performance Shares set forth above is referred to in this Award Notice as the “Target Opportunity.”  The Plan and the Committee’s Administrative Rules (“Rules”) govern the operation of the Plan, as well as the terms and conditions of Your ROC Performance Shares, and are incorporated herein by reference.  Capitalized terms not otherwise defined herein shall have the meanings set forth for such terms in the Plan or the Rules.
1.    Performance Cycle and Performance Goal
The vesting of Your ROC Performance Shares is subject to a Performance Goal as set forth in this Award Notice.  The Performance Cycle for Your ROC Performance Shares is [start date] through [end date].  Except as otherwise specified in the Plan or determined by the Committee, and to the extent the Performance Goal has been achieved, Your ROC Performance Shares shall vest on such date as the Committee determines the extent to which the Performance Goal has been achieved.  Such determination date shall be not later than [date].
The Performance Goal upon which any vesting and payment of Your ROC Performance Shares is conditioned shall be the Total Return on Capital (as defined below) of the Company over the Performance Cycle relative to the Total Return on Capital of other companies in the Report Group (as defined below) for the Performance Cycle.  Total Return on Capital for the Company or any member of the Report Group shall mean the average of the returns on capital for each twelve month period corresponding to each of the Company’s fiscal years during the 

Performance Cycle, based on the data reported for that company in the Bloomberg online database (or, if the Bloomberg database ceases to be available, such alternative publication or service as the Compensation Committee shall designate) for the following group of companies for which data is available for the entire Performance Cycle (the “Report Group”):  
Atmos Energy Corporation
Cabot Oil & Gas Corporation
Energen Corporation
EQT Corporation
MDU Resources Group Inc.
National Fuel Gas Company
New Jersey Resources Corporation
Range Resources Corporation
SM Energy Company
Southwest Gas Corporation
Southwestern Energy Company
Spire Inc.
UGI Corporation
WGL Holdings Inc. 
Whiting Petroleum Corporation
Notwithstanding the foregoing, in comparing the Company’s performance to that of the Report Group, the Committee shall adjust the Company’s Total Return on Capital to include the effect of discontinued operations.  To the extent reasonably correctible, the Committee shall correct the reported data for a known error in the reporting of the results of the Company. Furthermore, to the extent a company in the Report Group ceases to exist due to bankruptcy, delisting, liquidation or any other reason as determined and approved by the Committee, that company shall not be removed from the Report Group and shall be considered to have performed at a level ranking it at the bottom of the Report Group. 
The term “Percentile Ranking” as used in this Award Notice in reference to Total Return on Capital means the percentage determined by dividing:
		
	(A)
	the remainder of the Company’s rank within the Report Group for the Performance Cycle (measured lowest to highest) based on its Total Return on Capital for the Performance Cycle, minus one (1), 

by 
		
	(B)
	the number of companies (excluding the Company) in the Report Group for that Performance Cycle.

For purposes of determining the Company’s rank within the Report Group, if the Company’s Total Return on Capital for a Performance Cycle equals that of another company in the Report Group, the Company shall be ranked ahead of such other company.
Your ROC Performance Shares shall vest and payment shall be made on Your ROC Performance Shares to the extent the Company achieves the Percentile Ranking detailed below, 

provided that Your ROC Performance Shares have not previously been forfeited in accordance with applicable terms and conditions. 
	
		
	Company’s
Percentile Ranking
	Percentage of
Target Opportunity Paid

	 
	 

	< 45th
	0%

	45th
	50%

	60th
	100%

	75th
	150%

	100th
	200%

Notwithstanding the foregoing, if the Company’s Total Return on Capital is negative (less than 0.0), the percentage of Target Opportunity paid shall be capped at 100%.  For performance between two established performance levels, the percentage of Target Opportunity paid will be determined by mathematical interpolation.  
Any and all of Your ROC Performance Shares representing the percentage of the Target Opportunity not required to be paid shall not vest, and shall be automatically forfeited on the date the Compensation Committee makes its determination as to the extent to which the Performance Goal has been achieved, but no later than [date], if not previously forfeited in accordance with the terms and conditions applicable to such Performance Shares.
2.    Settlement
At the expiration of the Performance Cycle, the Committee shall certify in writing the number of Performance Shares earned and vested on the basis of performance in relation to the Performance Goal.  The Committee shall determine whether earned Performance Shares are to be distributed in the form of cash, shares of Common Stock or in a combination thereof, with the value or number of shares payable to be determined based on the Fair Market Value of the Common Stock on the date of the Committee’s certification.  Any fractional share otherwise payable in settlement of Your ROC Performance Shares shall be paid in cash. 
3.    Restrictions on Transferability
Your ROC Performance Shares may not be sold, assigned, transferred or pledged during the Performance Cycle, except that the Committee may permit (on such terms and conditions as it shall establish) some or all of Your ROC Performance Shares to be transferred during the Performance Cycle to a Permitted Transferee in accordance with Section 14(a) of the Plan.
4.    Rights as a Shareholder
You shall not have any right, in respect of Your ROC Performance Shares, to vote on any matter submitted to the Company’s stockholders until such time, if any, as the shares of Common Stock attributable to Your ROC Performance Shares have been issued.  Dividend Equivalents shall not be paid or payable on Your ROC Performance Shares before they become earned and vested.

5.    Termination of Employment
In the event your employment with the Company or its Subsidiaries terminates due to your death, Disability or Retirement, or due to the Company divestiture of one or more Subsidiaries or other business segments, divisions or operations in a transaction that does not otherwise qualify as a Change in Control, then the number of Your ROC Performance Shares that otherwise would have vested after the end of the Performance Cycle shall be pro-rated to reflect the time period from the commencement of the Performance Cycle through the date of the termination of your service to the Company or its Subsidiaries, as described in Sections 11(a)(i) and 11(c)(i), respectively, of the Plan, and any of Your ROC Performance Shares that do not vest shall automatically be forfeited.  In the event your employment with the Company or its Subsidiaries terminates for any other reason, the provisions of the Plan shall control.
6.    Change in Control
Subject to the terms of the Plan and the Rules, in the event of a Change in Control of the Company, each of Your ROC Performance Shares then outstanding shall be deemed earned at the target level of performance for such Award.  In addition, the Committee may direct that each of Your ROC Performance Shares be settled in cash with its value determined based on the value received by the shareholders in any transaction that constitutes a Change in Control.  The Plan also allows the Committee to reasonably determine in good faith, before a Change in Control, that this Award shall be honored or assumed, or new rights substituted therefore, by your employer or the parent or affiliate of your employer, provided that any such honored, assumed or substituted award must satisfy the requirements set forth in Section 12(b) of the Plan, including “substantially equivalent economic value.”  
7.    Adjustments in Common Stock
In the event of an Adjustment Event, including any stock dividend, stock split, merger, consolidation, reorganization, recapitalization or other similar event affecting the Common Stock, the Committee shall equitably adjust, in its discretion, the number of shares subject to this Award Notice.  To the extent the Committee deems equitable and appropriate and subject to any required action by shareholders of the Company or of any successor in interest to the Company or any direct or indirect parent corporation of the Company or any such successor, in any Adjustment Event that is a merger, consolidation, reorganization, liquidation, dissolution or similar transaction, Your ROC Performance Shares shall be deemed to pertain to the securities and other property, including cash, to which a holder of the number of shares of Common Stock covered by this Award Notice would have been entitled to receive in connection with such Adjustment Event.  Any Committee determination pursuant to this Section 7 shall be final, binding and conclusive.
8.    Authority of Committee 
The Committee has the authority to interpret the Plan and all Performance Shares granted thereunder, to establish rules and regulations relating to the Plan and to make all other determinations it believes necessary or advisable for the administration of the Plan.  The scope of 

the Committee’s authority is more fully described in Section 3 of the Plan.  All determinations and actions of the Committee are final, conclusive and binding on you. 
9.    Miscellaneous
(a)    This Award Notice shall be binding upon and inure to the benefit of the Company (and its successors and assigns) and you (and your heirs, legal representatives and estate) and shall be governed by the laws of the State of New Jersey, and any applicable laws of the United States.  The Performance Share award under the Plan does not alter, amend or otherwise affect your employment status with the Company or its subsidiaries.  No contract or right of employment shall be implied by this Award Notice.
(b)    The Committee may at any time unilaterally amend any unpaid Performance Shares award, including Awards earned but not yet paid, to the extent it deems appropriate, provided, however, that subject to Section 5(d) of the Plan, any such amendment which is adverse to the Grantee shall require the Grantee’s consent unless the Committee determines that such amendment or modification is necessary or advisable to comply with applicable law as a result of changes in law or regulation or to avoid the imposition of an additional tax, interest or penalty under Section 409A of the Internal Revenue Code of 1986, as amended.
(c)    If Your ROC Performance Shares are assumed or new Performance Shares are substituted therefor in any corporate reorganization (including, but not limited to, any transaction of the type referred to in Section 424(a) of the Internal Revenue Code of 1986, as amended), employment by such assuming or substituting company or by a parent company or a subsidiary thereof shall be considered for all purposes of this Award Notice to be employment by the Company.
(d)    In consideration of the Grantee’s privilege to participate in the Plan, the Grantee agrees (i) not to disclose any trade secrets of, or other confidential/restricted information of the Company to any unauthorized party, (ii) not to make any unauthorized use of such trade secrets or confidential or restricted information during his or her employment with the Company or its Subsidiaries or after such employment is terminated, and (iii) not to solicit any then current employees of the Company or any other subsidiaries of the Company to join the Grantee at his or her new place of employment after his or her employment with the Company or its Subsidiaries is terminated. Pursuant to 18 U.S.C. § 1833(b), an individual shall not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that is made: (1) in confidence to a Federal, State, or local government official, either directly or indirectly, or to an attorney, and solely for the purpose of reporting or investigating a suspected violation of law; or (2) in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal.  Additionally, an individual who files a lawsuit for retaliation by an employer for reporting a suspected violation of law may disclose a trade secret to his or her attorney and use the trade secret information in the court proceeding, if the individual: (1) files any document containing the trade secret under seal; and (2) does not disclose the trade secret, except pursuant to court order.

(e)    This Award Notice, together with the Plan and the Rules, constitutes the entire agreement between the parties with respect to the subject matter hereof.  You hereby acknowledge that you have been provided with a copy of the Plan and the Rules, and understand the terms and conditions of these documents and of this Award Notice.  
(f)    In the event of the invalidity of any part or provision of this Award Notice, such invalidity shall not affect the enforceability of any other part or provision hereof.
10.    Tax Withholding
The Company will be entitled to deduct from any payment under this Award Notice, regardless of the form of such payment, the amount of all applicable income and employment taxes required by law to be withheld with respect to such payment or may require you to pay to it such tax prior to and as a condition of the making of such payment.  Tax withholdings will be in accordance with the Rules. 
11.    Securities Law Requirements
The Company will not be required to issue shares in settlement of Your ROC Performance Shares unless and until (a) such shares have been duly listed upon each stock exchange on which the Company’s Common Stock is then registered and (b) a registration statement under the Securities Act of 1933 with respect to such shares is then effective.  The Board may require you to furnish to the Company, prior to the issuance of any shares of Common Stock in connection with the settlement of Your ROC Performance Shares, an agreement, in such form as the Board may from time to time deem appropriate, in which you represent that the shares you acquired upon such settlement are being acquired for investment and not with a view to the sale or distribution thereof.
12.    Performance Shares Subject to Plan and Rules
Your ROC Performance Shares shall be subject to all the terms and provisions of the Plan, the Rules and this Award Notice, and you shall abide by and be bound by such terms and provisions and all rules, regulations and determinations of the Board or the Committee now or hereafter made in its discretion in connection with the administration of the Plan.  
13.    American Jobs Creation Act
In addition to amendments permitted by Section 9(b) above, the Company may make amendments to Your ROC Performance Shares, without your consent, in order to ensure compliance with the American Jobs Creation Act of 2004.  And, further, amendments may be made to the Plan to ensure such compliance, which amendments may impact Your ROC Performance Shares.

If the foregoing is acceptable to you, kindly acknowledge your acceptance by clicking the "Accept" button below.  By clicking the "Accept" button, you acknowledge that you have read the terms and conditions of the grant, and agree to be bound by those terms and conditions. 
Very truly yours,
	
			
	NATIONAL FUEL GAS COMPANY
	 

	 
	 
	 

	By:
	 
	 

	 
	[Name]
	 

	 
	[Title]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00278-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00278-of-00352.parquet"}]]